These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 26728611)

  • 1. Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac.
    Winkler S; Springorum HR; Vaitl T; Handel M; Barta S; Kehl V; Craiovan B; Grifka J
    Int Orthop; 2016 Apr; 40(4):673-80. PubMed ID: 26728611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative blood loss and gastrointestinal tolerability of etoricoxib and diclofenac in total hip arthroplasty (ETO-DIC study): a single-center, prospective double-blinded randomized controlled trial.
    Winkler SH; Barta S; Kehl V; Schröter C; Wagner F; Grifka J; Springorum HR; Craiovan B
    Curr Med Res Opin; 2016; 32(1):37-47. PubMed ID: 26414653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?
    Brunnekreef JJ; Hoogervorst P; Ploegmakers MJ; Rijnen WH; Schreurs BW
    Int Orthop; 2013 Apr; 37(4):583-7. PubMed ID: 23359100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diclofenac for prophylaxis of heterotopic ossification after hip arthroplasty: a systematic review.
    Haffer H; Müller M; Ascherl R; Perka C; Winkler T
    Hip Int; 2022 Mar; 32(2):144-151. PubMed ID: 33272062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
    van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
    Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No difference between two doses of diclofenac in prophylaxis of heterotopic ossifications after total hip arthroplasty.
    Sell S; Phillips O; Handel M
    Acta Orthop Scand; 2004 Feb; 75(1):45-9. PubMed ID: 15022805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective COX-2 Inhibitors Significantly Reduce the Occurrence of Heterotopic Ossification After Hip Arthroscopic Surgery.
    Rath E; Warschawski Y; Maman E; Dolkart O; Sharfman ZT; Salai M; Amar E
    Am J Sports Med; 2016 Mar; 44(3):677-81. PubMed ID: 26695395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etoricoxib is safe and effective in preventing heterotopic ossification after primary total hip arthroplasty.
    Oberberg S; Nottenkämper J; Heukamp M; Krapp J; Willburger RE
    J Orthop Surg Res; 2021 Feb; 16(1):163. PubMed ID: 33639986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative irradiation versus the use of nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement: the results of a randomized trial.
    Kölbl O; Knelles D; Barthel T; Raunecker F; Flentje M; Eulert J
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):397-401. PubMed ID: 9788422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of periarticular heterotopic ossification after endoprosthetic hip joint replacement by means of diclofenac.
    Jockheck M; Willms R; Volkmann R; Sell S; Weller S; Küsswetter W
    Arch Orthop Trauma Surg; 1998; 117(6-7):337-40. PubMed ID: 9709846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up.
    Grohs JG; Schmidt M; Wanivenhaus A
    Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterotopic ossification after total hip arthroplasty: When is development completed?
    Willburger RE; Brinkhoff F; Nottenkämper J; Krapp J; Oberberg S
    J Orthop Surg Res; 2022 Mar; 17(1):147. PubMed ID: 35248082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials].
    Xu BG; Xue DT; Wang XH; Yan SG
    Zhongguo Gu Shang; 2014 Jul; 27(7):609-14. PubMed ID: 25338452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial comparing early postoperative irradiation vs. the use of nonsteroidal antiinflammatory drugs for prevention of heterotopic ossification following prosthetic total hip replacement.
    Kölbl O; Knelles D; Barthel T; Kraus U; Flentje M; Eulert J
    Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):961-6. PubMed ID: 9392532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
    Cannon CP; Curtis SP; FitzGerald GA; Krum H; Kaur A; Bolognese JA; Reicin AS; Bombardier C; Weinblatt ME; van der Heijde D; Erdmann E; Laine L;
    Lancet; 2006 Nov; 368(9549):1771-81. PubMed ID: 17113426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterotopic ossification following total hip arthroplasty. Which is the predominant risk factor: surgical approach or post-operative prophylaxis?
    Olivero M; Garg AK; Cañones M; San Francisco FO; Adarraga JM; Chawla A; Lopez-Subias J; Garijo RL; Marín-Peña O
    Int Orthop; 2024 Nov; 48(11):2853-2861. PubMed ID: 39254721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention of heterotopic ossification after total hip arthroplasty: A meta-analysis.
    Zhu XT; Chen L; Lin JH
    Medicine (Baltimore); 2018 Aug; 97(31):e11649. PubMed ID: 30075549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment on Brunnekreef et al.: Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?
    Zhang H; Guo W; Zhang KN; Lou ZY
    Int Orthop; 2013 Aug; 37(8):1629. PubMed ID: 23736968
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of Heterotopic Ossification Following a Multimodal Pain Protocol in Total Hip Arthroplasty With the Posterior Approach.
    White PB; Ramkumar PN; Meftah M; Ghazi N; Ranawat AS; Ranawat CS
    Orthopedics; 2018 Jan; 41(1):e92-e97. PubMed ID: 29120007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to comment on Brunnekreef et al.: Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?
    Brunnekreef JJ; Schreurs BW
    Int Orthop; 2013 Aug; 37(8):1631. PubMed ID: 23778642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.